Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

[Regulation of human β-1,4-galactosyltransferase V gene expression in cancer cells].

Sato T, Furukawa K.

Yakugaku Zasshi. 2012;132(6):691-7. Review.

3.

Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.

Kumagai T, Sato T, Natsuka S, Kobayashi Y, Zhou D, Shinkai T, Hayakawa S, Furukawa K.

Glycoconj J. 2010 Oct;27(7-9):685-95. doi: 10.1007/s10719-010-9313-2. Epub 2010 Nov 6.

4.
5.

Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines.

Sato T, Shirane K, Kido M, Furukawa K.

Biochem Biophys Res Commun. 2000 Oct 5;276(3):1019-23.

PMID:
11027584
6.

Involvement of beta-1,4-galactosyltransferase V in malignant transformation-associated changes in glycosylation.

Shirane K, Sato T, Segawa K, Furukawa K.

Biochem Biophys Res Commun. 1999 Nov 19;265(2):434-8.

PMID:
10558885
7.

Early lethality of beta-1,4-galactosyltransferase V-mutant mice by growth retardation.

Kumagai T, Tanaka M, Yokoyama M, Sato T, Shinkai T, Furukawa K.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):456-9. doi: 10.1016/j.bbrc.2008.12.078. Epub 2008 Dec 27.

PMID:
19114028
8.

Differential gene expression of beta-1,4-galactosyltransferases I, II and V during mouse brain development.

Nakamura N, Yamakawa N, Sato T, Tojo H, Tachi C, Furukawa K.

J Neurochem. 2001 Jan;76(1):29-38.

9.

Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.

Zhu X, Jiang J, Shen H, Wang H, Zong H, Li Z, Yang Y, Niu Z, Liu W, Chen X, Hu Y, Gu J.

J Biol Chem. 2005 Apr 1;280(13):12503-16. Epub 2004 Dec 16.

10.
11.

Regulation of lactosylceramide synthase (glucosylceramide beta1-->4 galactosyltransferase); implication as a drug target.

Chatterjee S, Kolmakova A, Rajesh M.

Curr Drug Targets. 2008 Apr;9(4):272-81. Review.

PMID:
18393821
12.

Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.

Wei Y, Liu D, Zhou F, Ge Y, Xu J, Yun X, Gu J, Jiang J.

J Hepatol. 2008 Dec;49(6):1029-37. doi: 10.1016/j.jhep.2008.09.003. Epub 2008 Sep 26.

PMID:
18929424
13.

Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Lee A, Chick JM, Kolarich D, Haynes PA, Robertson GR, Tsoli M, Jankova L, Clarke SJ, Packer NH, Baker MS.

Mol Cell Proteomics. 2011 Sep;10(9):M900538MCP200. doi: 10.1074/mcp.M900538-MCP200. Epub 2010 Feb 18.

14.

Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma.

Xu S, Zhu X, Zhang S, Yin S, Zhou L, Chen C, Gu J.

J Cancer Res Clin Oncol. 2001 Aug;127(8):502-6.

PMID:
11501750
15.

Arachidonic acid induces an increase of β-1,4-galactosyltransferase I expression in MDA-MB-231 breast cancer cells.

Villegas-Comonfort S, Serna-Marquez N, Galindo-Hernandez O, Navarro-Tito N, Salazar EP.

J Cell Biochem. 2012 Nov;113(11):3330-41. doi: 10.1002/jcb.24209.

PMID:
22644815
17.

Expression change of beta-1,4 galactosyltransferase I, V mRNAs and Galbeta1,4GlcNAc group in rat sciatic nerve after crush.

Yan M, Cheng C, Shao X, Qian J, Shen A, Xia C.

J Mol Histol. 2008 Jun;39(3):317-28. doi: 10.1007/s10735-008-9168-z. Epub 2008 Mar 5. Erratum in: J Mol Histol. 2008 Aug;39(4):469. Xia, Chun [corrected to Xia, Chunlin].

PMID:
18320333
18.

Osteopontin increases the expression of β1, 4-galactosyltransferase-I and promotes adhesion in human RL95-2 cells.

Zhu F, Shen F, Fan Y, Xie Y, Xia Y, Kong Y.

Glycoconj J. 2012 Aug;29(5-6):347-56. doi: 10.1007/s10719-012-9426-x. Epub 2012 Jul 31.

PMID:
22847114
20.

The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.

van Die I, van Tetering A, Schiphorst WE, Sato T, Furukawa K, van den Eijnden DH.

FEBS Lett. 1999 Apr 30;450(1-2):52-6.

Items per page

Supplemental Content

Write to the Help Desk